Adagene (ADAG) News Today $1.82 -0.12 (-6.19%) As of 07/3/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADAG Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Adagene stock jumps after Sanofi’s $25 million strategic investmentJuly 3 at 6:07 PM | uk.investing.comAdagene Inc. (ADAG) Latest Stock News & Headlines - Yahoo FinanceJuly 2 at 9:17 AM | finance.yahoo.comAdagene ADRs Rise Following Sanofi InvestmentJuly 1, 2025 | marketwatch.comAdagene Shares Climb on Strengthened Collaboration and $25M Investment from SanofiJuly 1, 2025 | msn.comAdagene announces up to $25 million strategic investment from SanofiJuly 1, 2025 | globenewswire.comAdagene (NASDAQ:ADAG) Trading 0.3% Higher - Here's WhyJune 24, 2025 | marketbeat.comAdagene Inc. (NASDAQ:ADAG) Sees Significant Growth in Short InterestJune 1, 2025 | marketbeat.comAdagene to Present at Jefferies Global Healthcare Conference 2025May 27, 2025 | globenewswire.comAdagene (NASDAQ:ADAG) Trading Down 2.1% - Here's WhyMay 25, 2025 | marketbeat.comAdagene Inc. Reports Positive Phase 1b/2 Results of ADG126 with Pembrolizumab in Advanced Microsatellite Stable Colorectal CancerMay 24, 2025 | nasdaq.comAdagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at the American Society of ...May 24, 2025 | finance.yahoo.comAdagene Inc.: Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA (pembrolizumab) in Colorectal Cancer at the American ...May 23, 2025 | finanznachrichten.deAdagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at the American Society of Clinical Oncology (ASCO) Annual MeetingMay 22, 2025 | globenewswire.comAdagene Inc. (NASDAQ:ADAG) Short Interest UpdateMay 2, 2025 | marketbeat.comAdagene Appoints John Maraganore, Ph.D. as Executive AdvisorApril 28, 2025 | globenewswire.comAdagene Announces Upcoming Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at American Society of Clinical Oncology (ASCO) Annual MeetingApril 23, 2025 | globenewswire.comAdagene Inc. (NASDAQ:ADAG) Short Interest Up 265.6% in MarchApril 17, 2025 | marketbeat.comAdagene Inc. (NASDAQ:ADAG) Shares Sold by FIL LtdApril 15, 2025 | marketbeat.comFY2025 Earnings Estimate for Adagene Issued By HC WainwrightApril 8, 2025 | marketbeat.comAdagene to Present at Stifel’s 2025 Virtual Targeted Oncology ForumApril 7, 2025 | markets.businessinsider.comAdagene (NASDAQ:ADAG) Earns "Buy" Rating from HC WainwrightApril 5, 2025 | marketbeat.comAdagene And 2 Other Promising Penny Stocks To WatchApril 2, 2025 | finance.yahoo.comAdagene Reports 33% Overall Response Rate in Phase 2 Expansion of Muzastotug for MSS CRC, Highlights Financial Position and Future MilestonesMarch 26, 2025 | nasdaq.comAdagene (ADAG) to Release Quarterly Earnings on ThursdayMarch 25, 2025 | marketbeat.comAdagene reports FY24 adjusted EPS (51c), consensus (58c)March 25, 2025 | markets.businessinsider.comAdagene Reports Full Year 2024 Financial Results and Provides Corporate UpdateMarch 25, 2025 | markets.businessinsider.comAdagene Inc. Reports 2024 Financial Results and ProgressMarch 24, 2025 | tipranks.comAdagene Reports 2024 Financial Results and Advances Clinical ProgramsMarch 24, 2025 | tipranks.comAdagene Reports Full Year 2024 Financial Results and Provides Corporate UpdateMarch 24, 2025 | globenewswire.comAdagene Inc. (NASDAQ:ADAG) Short Interest Down 55.9% in FebruaryMarch 14, 2025 | marketbeat.comAdagene to Present at 11th Annual Immuno-Oncology 360° SummitMarch 13, 2025 | tmcnet.comAdagene Inc. to Present ADG126 SAFEbody® Data at 11th Annual Immuno-Oncology 360⁰ Summit in BostonMarch 13, 2025 | quiverquant.comQAdagene to Present at 11th Annual Immuno-Oncology 360⁰ SummitMarch 13, 2025 | globenewswire.comGeneral Atlantic L.P. Acquires 3,561,952 Shares of Adagene Inc. (NASDAQ:ADAG)March 11, 2025 | marketbeat.comAdagene (NASDAQ:ADAG) Stock Price Up 0.2% - Still a Buy?March 7, 2025 | marketbeat.comAdagene to Present at Leerink’s Global Healthcare Conference 2025March 6, 2025 | finance.yahoo.comAdagene to Present at Leerink's Global Healthcare Conference 2025March 6, 2025 | globenewswire.comAdagene begins Phase 2 trial for neoadjuvant muzastotug in colorectal cancerFebruary 27, 2025 | markets.businessinsider.comAdagene Inc. to Initiate Phase 2 Trial of ADG126 for Colorectal Cancer with Enrollment Starting in April 2025February 27, 2025 | quiverquant.comQAdagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug (ADG126) in Colorectal CancerFebruary 27, 2025 | globenewswire.comAdagene (NASDAQ:ADAG) Rating Lowered to Equal Weight at Morgan StanleyJanuary 31, 2025 | marketbeat.comMorgan Stanley downgrades Adagene (ADAG) to a HoldJanuary 31, 2025 | markets.businessinsider.comAdagene downgraded to Equal Weight from Overweight at Morgan StanleyJanuary 31, 2025 | markets.businessinsider.comCD47 Inhibitor Drug Clinical Trials Market Opportunity Outlook 2028, Competitive Analysis of Adagene, ALX, ImmuneOncia, ImmuneOnco, Light Chain Bioscience, Phanes, and Virtuoso,January 29, 2025 | globenewswire.comFY2024 Earnings Forecast for Adagene Issued By HC WainwrightJanuary 29, 2025 | marketbeat.comFY2029 Earnings Estimate for Adagene Issued By HC WainwrightJanuary 28, 2025 | marketbeat.comAdagene announces updated data from Phase 1b/2 study of muzastotug, keytrudaJanuary 27, 2025 | markets.businessinsider.comAdagene price target raised to $8 from $5 at H.C. WainwrightJanuary 27, 2025 | msn.comAdagene’s ADG126: Promising Efficacy and Safety Profile Justifies Buy RatingJanuary 27, 2025 | markets.businessinsider.comH.C. Wainwright lifts Adagene stock target to $8 on ASCO dataJanuary 27, 2025 | msn.com Get Adagene News Delivered to You Automatically Sign up to receive the latest news and ratings for ADAG and its competitors with MarketBeat's FREE daily newsletter. Email Address ADAG Media Mentions By Week ADAG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADAG News Sentiment▼0.200.58▲Average Medical News Sentiment ADAG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADAG Articles This Week▼51▲ADAG Articles Average Week Get Adagene News Delivered to You Automatically Sign up to receive the latest news and ratings for ADAG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARCT News Today MBX News Today CMPX News Today TERN News Today HUMA News Today PRTA News Today HRTX News Today AMRN News Today PRME News Today SNDL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADAG) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adagene Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Adagene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
